Medexus Pharmaceuticals Inc historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2024-03-04 | 1.800 | 1.810 | 1.710 | 1.720 | 1.720 | 18,500 |
| 2024-03-01 | 1.790 | 1.860 | 1.750 | 1.820 | 1.820 | 32,900 |
| 2024-02-29 | 1.850 | 1.850 | 1.750 | 1.770 | 1.770 | 73,900 |
| 2024-02-28 | 1.820 | 1.870 | 1.790 | 1.800 | 1.800 | 53,900 |
| 2024-02-27 | 1.770 | 1.800 | 1.750 | 1.790 | 1.790 | 36,000 |
| 2024-02-26 | 1.720 | 1.770 | 1.690 | 1.750 | 1.750 | 50,600 |
| 2024-02-23 | 1.720 | 1.730 | 1.640 | 1.700 | 1.700 | 19,400 |
| 2024-02-22 | 1.770 | 1.770 | 1.670 | 1.690 | 1.690 | 16,500 |
| 2024-02-21 | 1.650 | 1.760 | 1.600 | 1.750 | 1.750 | 47,000 |
| 2024-02-20 | 1.750 | 1.750 | 1.640 | 1.640 | 1.640 | 26,500 |
| 2024-02-16 | 1.780 | 1.800 | 1.700 | 1.750 | 1.750 | 31,900 |
| 2024-02-15 | 1.800 | 1.870 | 1.780 | 1.790 | 1.790 | 42,300 |
| 2024-02-14 | 1.670 | 1.900 | 1.670 | 1.780 | 1.780 | 62,400 |
| 2024-02-13 | 1.780 | 1.780 | 1.660 | 1.670 | 1.670 | 48,600 |
| 2024-02-12 | 1.860 | 2.000 | 1.710 | 1.790 | 1.790 | 149,100 |
| 2024-02-09 | 1.790 | 1.890 | 1.660 | 1.870 | 1.870 | 201,300 |
| 2024-02-08 | 2.350 | 2.350 | 1.750 | 1.920 | 1.920 | 417,000 |
| 2024-02-07 | 2.670 | 2.840 | 2.660 | 2.700 | 2.700 | 49,400 |
| 2024-02-06 | 2.580 | 2.680 | 2.540 | 2.670 | 2.670 | 24,900 |
| 2024-02-05 | 2.490 | 2.580 | 2.410 | 2.580 | 2.580 | 34,500 |
| 2024-02-02 | 2.360 | 2.520 | 2.320 | 2.450 | 2.450 | 54,500 |
| 2024-02-01 | 2.390 | 2.390 | 2.310 | 2.340 | 2.340 | 31,400 |
| 2024-01-31 | 2.380 | 2.400 | 2.280 | 2.320 | 2.320 | 54,800 |
| 2024-01-30 | 2.500 | 2.500 | 2.350 | 2.360 | 2.360 | 67,200 |
| 2024-01-29 | 2.550 | 2.580 | 2.480 | 2.490 | 2.490 | 31,100 |
| 2024-01-26 | 2.550 | 2.590 | 2.500 | 2.550 | 2.550 | 32,900 |
| 2024-01-25 | 2.610 | 2.610 | 2.510 | 2.540 | 2.540 | 29,000 |
| 2024-01-24 | 2.450 | 2.640 | 2.450 | 2.550 | 2.550 | 39,900 |
| 2024-01-23 | 2.510 | 2.530 | 2.430 | 2.430 | 2.430 | 30,000 |
| 2024-01-22 | 2.540 | 2.540 | 2.410 | 2.510 | 2.510 | 26,300 |
| 2024-01-19 | 2.510 | 2.550 | 2.390 | 2.500 | 2.500 | 65,900 |
| 2024-01-18 | 2.650 | 2.660 | 2.530 | 2.530 | 2.530 | 15,100 |
| 2024-01-17 | 2.680 | 2.680 | 2.520 | 2.610 | 2.610 | 42,400 |
| 2024-01-16 | 2.950 | 2.950 | 2.570 | 2.680 | 2.680 | 87,800 |
| 2024-01-15 | 2.880 | 2.900 | 2.820 | 2.850 | 2.850 | 73,800 |
| 2024-01-12 | 2.440 | 2.700 | 2.440 | 2.660 | 2.660 | 42,300 |
| 2024-01-11 | 2.690 | 2.690 | 2.430 | 2.430 | 2.430 | 103,300 |
| 2024-01-10 | 2.860 | 2.860 | 2.650 | 2.680 | 2.680 | 70,200 |
| 2024-01-09 | 3.150 | 3.150 | 2.780 | 2.850 | 2.850 | 106,300 |
| 2024-01-08 | 2.990 | 3.160 | 2.920 | 3.120 | 3.120 | 103,800 |
| 2024-01-05 | 2.640 | 2.880 | 2.640 | 2.870 | 2.870 | 92,100 |
| 2024-01-04 | 2.610 | 2.700 | 2.550 | 2.600 | 2.600 | 84,000 |
| 2024-01-03 | 2.600 | 2.620 | 2.480 | 2.580 | 2.580 | 36,900 |
| 2024-01-02 | 2.500 | 2.610 | 2.450 | 2.550 | 2.550 | 21,400 |
| 2023-12-29 | 2.400 | 2.500 | 2.390 | 2.470 | 2.470 | 85,100 |
| 2023-12-28 | 2.350 | 2.380 | 2.270 | 2.320 | 2.320 | 33,300 |
| 2023-12-27 | 2.210 | 2.340 | 2.210 | 2.290 | 2.290 | 30,500 |
| 2023-12-22 | 2.140 | 2.240 | 2.070 | 2.190 | 2.190 | 65,600 |
| 2023-12-21 | 2.070 | 2.110 | 2.060 | 2.100 | 2.100 | 62,100 |
| 2023-12-20 | 1.950 | 2.090 | 1.950 | 2.040 | 2.040 | 40,100 |
| 2023-12-19 | 1.730 | 2.050 | 1.730 | 1.900 | 1.900 | 131,600 |
| 2023-12-18 | 1.700 | 1.780 | 1.700 | 1.720 | 1.720 | 68,300 |
| 2023-12-15 | 1.700 | 1.720 | 1.670 | 1.670 | 1.670 | 19,800 |
| 2023-12-14 | 1.610 | 1.760 | 1.610 | 1.670 | 1.670 | 114,700 |
| 2023-12-13 | 1.540 | 1.600 | 1.540 | 1.600 | 1.600 | 13,600 |
| 2023-12-12 | 1.570 | 1.580 | 1.540 | 1.550 | 1.550 | 22,600 |
| 2023-12-11 | 1.570 | 1.600 | 1.540 | 1.550 | 1.550 | 26,900 |
| 2023-12-08 | 1.530 | 1.690 | 1.500 | 1.530 | 1.530 | 209,400 |
| 2023-12-07 | 1.550 | 1.550 | 1.510 | 1.520 | 1.520 | 11,000 |
| 2023-12-06 | 1.530 | 1.580 | 1.520 | 1.520 | 1.520 | 23,800 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (CAD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.